Skip to main content

Agilent Creates Life-Science Advisory Board

NEW YORK, Feb. 6 - Agilent Technologies has formed a life-sciences advisory board "to identify and evaluate technologies and applications" in the biotech sector, the company said Feb. 4.

 

"This is one more step toward accelerating our growth as a leading supplier of gene expression, proteomics and pharmaceutical analysis solutions," Chris Van Ingen, general manager of Agilent's life sciences and chemical analysis division, said in a statement.

 

Members of the board, which is expected to meet two or three times each year, include Paul Herring, director of corporate research at Novartis International; Anthony Martin, president and CEO of Molecular Probes.; Mark Skolnick, founder of Myriad Genetics; and, Wendell Wierenga, CEO of Syrrx.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.